<HTML>
<HEAD>
<TITLE>7.7.2 CSP - clinical study phase segment </TITLE>
<LINK REL="ToC" HREF="httoc.htm">
<LINK REL="Index" HREF="htindex.htm">
<LINK REL="Next" HREF="ch700029.htm">
<LINK REL="Previous" HREF="ch700027.htm"></HEAD>
<BODY BACKGROUND="images/grenszig.gif">
<P ALIGN=LEFT>
<A HREF="ch700027.htm" TARGET="_self"><IMG SRC="images/blrprev.gif" WIDTH = 32 HEIGHT = 32 BORDER = 0 ALT="Previous Page"></A>
<A HREF="httoc.htm" TARGET="_self"><IMG SRC="images/blrtoc.gif" WIDTH = 32 HEIGHT = 32 BORDER = 0 ALT="TOC"></A>
<A HREF="htindex.htm" TARGET="_self"><IMG SRC="images/blrindex.gif" WIDTH = 32 HEIGHT = 32 BORDER = 0 ALT="Index"></A>
<A HREF="ch700029.htm" TARGET="_self"><IMG SRC="images/blrnext.gif" WIDTH = 32 HEIGHT = 32 BORDER = 0 ALT="Next Page"></A>
<P>

<A NAME="E12E303"></A>
<H3><B>7.7.2</B><B> </B><A NAME="I2"></A><A NAME="I3"></A><A NAME="I4"></A><A NAME="I5"></A><A NAME="I6"></A><A NAME="I7"></A><A NAME="I8"></A><B>CSP - clinical study phase segment</B><B> </B></H3>
<P>
<FONT FACE="Times New Roman">The CSP segment contains information on a patient&#146;s status for a particular phase of the study.  This segment is optional and is useful when a study has different evaluation intervals within it.  (See Section <A HREF="ch700021.htm#I9">7.5.1.2</A>, &quot;phase of a clinical trial.&quot;)  The CSP segment is implemented on a study-specific basis for messaging purposes.  The fact that the patient has entered a phase of the study that represents a certain treatment approach may need to be messaged to other systems, like pharmacy, nursing, or order entry.  It is also important to sponsors and data management centers for tracking patient progress through the study and monitoring the data schedule defined for each phase.  It may subsume OBR and OBX segments that follow it to indicate that these data describe the phase.</FONT>
<P>Figure 7-15.  CSP attributes

<CENTER><TABLE BORDER=1 CELLSPACING=1 >
<TR>
<TD WIDTH=49 ALIGN=center  VALIGN=top  BGCOLOR=#E5E5E5 >
<P>
<FONT SIZE="-1">SEQ</FONT>
</TD><TD WIDTH=49 VALIGN=top  BGCOLOR=#E5E5E5 >
<P>
<FONT SIZE="-1">LEN</FONT>
</TD><TD WIDTH=36 VALIGN=top  BGCOLOR=#E5E5E5 >
<P>
<FONT SIZE="-1">DT</FONT>
</TD><TD WIDTH=50 ALIGN=center  VALIGN=top  BGCOLOR=#E5E5E5 >
<P>
<FONT SIZE="-1">OPT</FONT>
</TD><TD WIDTH=48 VALIGN=top  BGCOLOR=#E5E5E5 >
<P>
<FONT SIZE="-1">RP/#</FONT>
</TD><TD WIDTH=44 VALIGN=top  BGCOLOR=#E5E5E5 >
<P>
<FONT SIZE="-1">TBL#</FONT>
</TD><TD WIDTH=53 VALIGN=top  BGCOLOR=#E5E5E5 >
<P>
<FONT SIZE="-1">ITEM#</FONT>
</TD><TD WIDTH=239 VALIGN=top  BGCOLOR=#E5E5E5 >
<P>
<FONT SIZE="-1">ELEMENT NAME</TD>
</TR></FONT>
<TR>
<TD WIDTH=49 ALIGN=center  VALIGN=top >
<P>
<FONT SIZE="-1">1</FONT>
</TD><TD WIDTH=49 VALIGN=top >
<P>
<FONT SIZE="-1">60</FONT>
</TD><TD WIDTH=36 VALIGN=top >
<P>
<FONT SIZE="-1">CE</FONT>
</TD><TD WIDTH=50 ALIGN=center  VALIGN=top >
<P>
<FONT SIZE="-1">R</FONT>
</TD><TD WIDTH=48 VALIGN=top ><BR></TD>
<TD WIDTH=44 VALIGN=top ><BR></TD>
<TD WIDTH=53 VALIGN=top >
<P>
<FONT SIZE="-1">01051</FONT>
</TD><TD WIDTH=239 VALIGN=top >
<P>
<FONT SIZE="-1">Study Phase ID</TD>
</TR></FONT>
<TR>
<TD WIDTH=49 ALIGN=center  VALIGN=top >
<P>
<FONT SIZE="-1">2</FONT>
</TD><TD WIDTH=49 VALIGN=top >
<P>
<FONT SIZE="-1">26</FONT>
</TD><TD WIDTH=36 VALIGN=top >
<P>
<FONT SIZE="-1">TS</FONT>
</TD><TD WIDTH=50 ALIGN=center  VALIGN=top >
<P>
<FONT SIZE="-1">R</FONT>
</TD><TD WIDTH=48 VALIGN=top ><BR></TD>
<TD WIDTH=44 VALIGN=top ><BR></TD>
<TD WIDTH=53 VALIGN=top >
<P>
<FONT SIZE="-1">01052</FONT>
</TD><TD WIDTH=239 VALIGN=top >
<P>
<FONT SIZE="-1">Date/time Study Phase Began</TD>
</TR></FONT>
<TR>
<TD WIDTH=49 ALIGN=center  VALIGN=top >
<P>
<FONT SIZE="-1">3</FONT>
</TD><TD WIDTH=49 VALIGN=top >
<P>
<FONT SIZE="-1">26</FONT>
</TD><TD WIDTH=36 VALIGN=top >
<P>
<FONT SIZE="-1">TS</FONT>
</TD><TD WIDTH=50 ALIGN=center  VALIGN=top >
<P>
<FONT SIZE="-1">O</FONT>
</TD><TD WIDTH=48 VALIGN=top ><BR></TD>
<TD WIDTH=44 VALIGN=top ><BR></TD>
<TD WIDTH=53 VALIGN=top >
<P>
<FONT SIZE="-1">01053</FONT>
</TD><TD WIDTH=239 VALIGN=top >
<P>
<FONT SIZE="-1">Date/time Study Phase Ended</TD>
</TR></FONT>
<TR>
<TD WIDTH=49 ALIGN=center  VALIGN=top >
<P>
<FONT SIZE="-1">4</FONT>
</TD><TD WIDTH=49 VALIGN=top >
<P>
<FONT SIZE="-1">60</FONT>
</TD><TD WIDTH=36 VALIGN=top >
<P>
<FONT SIZE="-1">CE</FONT>
</TD><TD WIDTH=50 ALIGN=center  VALIGN=top >
<P>
<FONT SIZE="-1">C</FONT>
</TD><TD WIDTH=48 VALIGN=top ><BR></TD>
<TD WIDTH=44 VALIGN=top ><BR></TD>
<TD WIDTH=53 VALIGN=top >
<P>
<FONT SIZE="-1">01054</FONT>
</TD><TD WIDTH=239 VALIGN=top >
<P>
<FONT SIZE="-1">Study Phase Evaluability</TD></TR></FONT></TABLE></CENTER><P>7.7.2.0  CSP  field definitions
<H4>7.7.2.1 Study phase ID  (CE)   01051</H4>
<P>
<FONT FACE="Courier New">Components:  &lt;identifier (ST)&gt; ^ &lt;text (ST)&gt; ^ &lt;name of coding system (ST)&gt; ^ &lt;alternate identifier (ST)&gt; ^ &lt;alternate text (ST)&gt; ^ &lt;name of alternate coding system (ST)&gt;</FONT>
<P>
<FONT FACE="Times New Roman">Definition:  This field identifies the phase of the study that a patient has entered.  The set of codes will generally be developed for each clinical trial, although there are patterns that trials in particular disease or prevention categories may follow.  The phase structure will be based on data collation and reporting needs for the study.  It is an operational structure and need not be discussed in the clinical trial protocol documentation or even made known to patient care or data collection personnel.  The coding system will usually be developed by the sponsor for multicentered clinical trials to standardize the receipt of automated data.  Local codes could be added if an additional local message is desired.  Otherwise, local coding conventions will be used.  Example:  2^Init Rx, Crs 1^NCI T93-0807 Phases</FONT>
<H4>7.7.2.2 Date/time study phase began  (TS)   01052</H4>
<P>
<FONT FACE="Times New Roman">Definition:  This field contains the date the patient began this phase interval.  The time is optional.</FONT>
<H4>7.7.2.3 Date/time study phase ended  (TS)   01053</H4>
<P>
<FONT FACE="Times New Roman">Definition:  This field contains the date the patient ended this phase interval.</FONT>
<H4>7.7.2.4 Study phase evaluability  (CE)   01054</H4>
<P>
<FONT FACE="Courier New">Components:  &lt;identifier (ST)&gt; ^ &lt;text (ST)&gt; ^ &lt;name of coding system (ST)&gt; ^ &lt;alternate identifier (ST)&gt; ^ &lt;alternate text (ST)&gt; ^ &lt;name of alternate coding system (ST)&gt;</FONT>
<P>
<FONT FACE="Times New Roman">Definition:  This field contains the disposition of the patient&#146;s data for this phase interval for quality control and data analysis purposes.  The set of codes will vary across clinical trials.  An example answer set:  Complete, Adverse Events Only, Outcome Only, None, Unknown.</FONT>
<P>
<P ALIGN=LEFT>
<A HREF="ch700027.htm" TARGET="_self"><IMG SRC="images/blrprev.gif" WIDTH = 32 HEIGHT = 32 BORDER = 0 ALT="Previous Page"></A>
<A HREF="httoc.htm" TARGET="_self"><IMG SRC="images/blrtoc.gif" WIDTH = 32 HEIGHT = 32 BORDER = 0 ALT="TOC"></A>
<A HREF="htindex.htm" TARGET="_self"><IMG SRC="images/blrindex.gif" WIDTH = 32 HEIGHT = 32 BORDER = 0 ALT="Index"></A>
<A HREF="ch700029.htm" TARGET="_self"><IMG SRC="images/blrnext.gif" WIDTH = 32 HEIGHT = 32 BORDER = 0 ALT="Next Page"></A>
</BODY></HTML>
